Livedoid vasculopathy- A thrombotic disease;Livedo-Vaskulopathie- Eine thrombotische Erkrankung

Vasa - Journal of Vascular Diseases

Volumn 42, Issue 5, 2013, Pages 317-322

  Kerk, Nina ^a   Goerge, Tobias ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Angina cutis; Leg ulcer; Livedo vasculitis; Rivaroxaban; Skin infarction; Thrombosis

Indexed keywords

5, 10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CARDIOLIPIN ANTIBODY; ENOXAPARIN; FOLIC ACID; IMMUNOGLOBULIN; LIPOPROTEIN; LUPUS ANTICOAGULANT; PROTEIN C; RIVAROXABAN; UNCLASSIFIED DRUG; WARFARIN;

ATROPHIE BLANCHE; CHRONIC VEIN INSUFFICIENCY; DIFFERENTIAL DIAGNOSIS; DISEASE ACTIVITY; DISEASE ASSOCIATION; HUMAN; HYALINE DEGENERATION; LIVEDO RACEMOSA; LIVEDOID VASCULOPATHY; MICROCIRCULATION; MICROTHROMBUS; PAIN; POLYARTERITIS NODOSA; QUALITY OF LIFE; REVIEW; RISK FACTOR; SKIN BLOOD VESSEL DISORDER; SKIN ULCER; SNEDDON SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS; ULCER; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; ANTICOAGULANTS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LEG ULCER; LIVEDO RETICULARIS; LOWER EXTREMITY; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; THROMBOSIS;

EID: 84883379409     PISSN: 03011526     EISSN: None     Source Type: Journal    
DOI: 10.1024/0301-1526/a000296     Document Type: Review

References (28)

1. Feldaker M, Hines EA, Jr., Kierland RR. Livedo reticularis with summer ulcerations. AMA Arch Derm. 1955 Jul; 72 (1): 31-42.
2. Jorizzo JL. Livedoid vasculopathy: what is it? Archives of Dermatology. 1998; 134 (4): 491-3.
3. Papi M, Didona B, De Pita O, Frezzolini A, Di Giulio S, De Matteis W, et al. Livedo vasculopathy vs small vessel cutaneous vasculitis: cytokine and platelet P-selectin studies. Archives of Dermatology. 1998; 134 (4): 447-52.
4. Callen JP. Livedoid vasculopathy: what it is and how the patient should be evaluated and treated.[comment]. Archives of Dermatology. 2006; 142 (11): 1481-2.
5. Fritsch P, Zelger B. Livedo vasculitis. Hautarzt. 1995 Mar; 46 (3): 215-24.
6. Hairston BR, Davis MD, Pittelkow MR, Ahmed I. Livedoid vasculopathy: further evidence for procoagulant pathogenesis. Archives of Dermatology. 2006; 142 (11): 1413-8.
7. Goerge T. Niedermolekulare Heparin-Therapie zur Behandlung der Livedovaskulopathie. Aktuelle Dermatologie. 2010; 36 (12): 484-7.
8. Copeman PW. Livedo reticularis. Signs in the skin of disturbance of blood viscosity and of blood flow. Br J Dermatol. 1975 Nov; 93 (5): 519-29.
9. Goerge T. [Livedoid vasculopathy. Pathogenesis, diagnosis and treatment of cutaneous infarction]. Hautarzt. 2011 Aug; 62 (8): 627-34; quiz 35.
10. Metz J, Sturm G. Atrophie blanche (so-called capillaritis alba). Hautarzt. 1974 Mar; 25 (3): 105-9.
11. Gray HR, Graham JH, Johnson W, Burgoon CF, Jr. Atrophie blanche: periodic painful ulcers of lower extremities. A clinical and histopathological entity. Arch Dermatol. 1966 Feb; 93 (2): 187-93.
12. Di Giacomo TB, Hussein TP, Souza DG, Criado PR. Frequency of thrombophilia determinant factors in patients with livedoid vasculopathy and treatment with anticoagulant drugs-a prospective study. J Eur Acad Dermatol Venereol. Nov; 24 (11): 1340-6.
13. Sunderkotter C, de Groot K. Therapie von Vaskulitiden und Vaskulopathien. Hautarzt. 2008; 59 (5): 382-93.
14. Goerge T, Weishaupt C, Metze D, Nowak-Gottl U, Sunderkotter C, Steinhoff M, et al. Livedoid vasculopathy in a pediatric patient with elevated lipoprotein(a) levels: prompt response to continuous low-molecular-weight heparin. Arch Dermatol. 2010 Aug; 146 (8): 927-8.
15. Vasconcelos R, Criado PR, Belda W, Jr. Livedoid vasculopathy secondary to high levels of lipoprotein(a). Br J Dermatol. May; 164 (5): 1111-3.
16. Angles-Cano E, de la Pena Diaz A, Loyau S. Inhibition of fibrinolysis by lipoprotein(a). Annals of the New York Academy of Sciences. 2001; 936: 261-75.
17. Verma R, Hadid TH, Dhamija R, Moad JC, Loehrke ME. Livedoid vasculopathy in a woman with multiple myeloma. South Med J. Aug; 103 (8): 848-9.
18. Yasue T. Livedoid vasculitis and central nervous system involvement in systemic lupus erythematosus. Archives of Dermatology. 1986; 122 (1): 66-70.
19. Hairston BR, Davis MD, Gibson LE, Drage LA. Treatment of livedoid vasculopathy with low-molecular-weight heparin: report of 2 cases. [see comment]. Archives of Dermatology. 2003; 139 (8): 987-90.
20. Schobess R, During C, Bidlingmaier C, Heinecke A, Merkel N, Nowak-Gottl U. Long-term safety and efficacy data on childhood venous thrombosis treated with a low molecular weight heparin: an open-label pilot study of once-daily versus twice-daily enoxaparin administration. Haematologica. 2006; 91 (12): 1701-4.
21. Meyer V, Schneider SW, Gorge T. Dermatologic aspects of anticoagulation. Hautarzt. 2010 Aug; 61 (8): 705-16; quiz 17-8.
22. Browning CE, Callen JP. Warfarin therapy for livedoid vasculopathy associated with cryofibrinogenemia and hyperhomocysteinemia. Archives of Dermatology. 2006; 142 (1): 75-8.
23. Meiss F, Marsch WC, Fischer M. Livedoid vasculopathy. The role of hyperhomocysteinemia and its simple therapeutic consequences. European Journal of Dermatology. 2006; 16 (2): 159-62.
24. Abou Rahal J, Ishak RS, Otrock ZK, Kibbi AG, Taher AT. Livedoid vasculopathy in a patient with lupus anticoagulant and MTHFR mutation: treatment with low-molecular-weight heparin. J Thromb Thrombolysis. 2012 Nov; 34 (4): 541-4.
25. Deng A, Gocke CD, Hess J, Heyman M, Paltiel M, Gaspari A. Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) treated successfully with tissue plasminogen activator. Archives of Dermatology. 2006; 142 (11): 1466-9.
26. Amital H, Levy Y, Shoenfeld Y. Use of intravenous immunoglobulin in livedo vasculitis. Clin Exp Rheumatol. 2000 May-Jun; 18 (3): 404-6.
27. Kreuter A, Gambichler T, Breuckmann F, Bechara FG, Rotterdam S, Stucker M, et al. Pulsed intravenous immunoglobulin therapy in livedoid vasculitis: an open trial evaluating 9 consecutive patients. J Am Acad Dermatol. 2004 Oct; 51 (4): 574-9.
28. Kerk N, Drabik A, Luger TA, Schneider SW, Goerge T. Rivaroxaban prevents painful cutaneous infarctions in livedoid vasculopathy. Br J Dermatol. 2013 Apr; 168 (4): 898-9.